Argitalpenak (29) JUAN MANUEL FERNANDEZ COSTA argitalpenak

2024

  1. Taurine activates the AKT-mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy

    Disease models & mechanisms, Vol. 17, Núm. 4

  2. The Tissue Engineering Revolution: From Bench Research to Clinical Reality

    Biomedicines

2023

  1. BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice

    Pharmaceutics, Vol. 15, Núm. 4

  2. Fundamentals and mechanisms

    Multiscale Cell-Biomaterials Interplay in Musculoskeletal Tissue Engineering and Regenerative Medicine (Elsevier), pp. 1-25

  3. Integrated Bioluminescent Immunoassays for High-Throughput Sampling and Continuous Monitoring of Cytokines

    Analytical Chemistry, Vol. 95, Núm. 23, pp. 8922-8931

  4. Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy

    Biofabrication, Vol. 15, Núm. 4

  5. Muscle-on-a-chip devices: a new era for in vitro modelling of muscular dystrophies

    Disease models & mechanisms, Vol. 16, Núm. 6

  6. Training-on-a-Chip: A Multi-Organ Device to Study the Effect of Muscle Exercise on Insulin Secretion in Vitro

    Advanced Materials Technologies, Vol. 8, Núm. 7

2022

  1. Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver

    Biomedicines, Vol. 10, Núm. 5

  2. Organs-on-Chips: Trends and Challenges in Advanced Systems Integration

    Advanced Materials Interfaces, Vol. 9, Núm. 33

  3. Xeno-free bioengineered human skeletal muscle tissue using human platelet lysate-based hydrogels

    Biofabrication, Vol. 14, Núm. 4

2021

  1. Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle

    Biofabrication, Vol. 13, Núm. 3

  2. Bioengineered in vitro skeletal muscles as new tools for muscular dystrophies preclinical studies

    Journal of Tissue Engineering, Vol. 12

  3. Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model

    FASEB Journal, Vol. 35, Núm. 10

  4. Plasmonic nanocrystals on polycarbonate substrates for direct and label-free biodetection of Interleukin-6 in bioengineered 3D skeletal muscles

    Nanophotonics, Vol. 10, Núm. 18, pp. 4477-4488

  5. Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

    Molecular Therapy - Nucleic Acids, Vol. 26, pp. 174-191

2020

  1. New volumetric CNT-doped gelatin-cellulose scaffolds for skeletal muscle tissue engineering

    Nanoscale Advances, Vol. 2, Núm. 7, pp. 2885-2896

  2. Rabphilin involvement in filtration and molecular uptake in Drosophila nephrocytes suggests a similar role in human podocytes

    DMM Disease Models and Mechanisms, Vol. 13, Núm. 9

2018

  1. MiR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Myotonic dystrophy: candidate small molecule therapeutics

    Drug Discovery Today, Vol. 22, Núm. 11, pp. 1740-1748